Abstract
Rabies infections in swine have been reported occasionally in recent years in certain geographic locations. Although a protective vaccine consisting of inactivated rabies virus is available for use in swine, searching for a more economically viable formulation for use in developing countries is always a priority. This work describes the testing of a canine adenovirus that expresses a rabies viral epitope (CAV-2-E3Delta-RGP) in a porcine rabies model. The data presented here show that the recombinant viral vaccine was effective in protecting swine against rabies if administered intramuscularly, but not orally or intranasally, and that protection was probably related to the development of a humoral response that lasted at least 28 weeks. Following vaccination, no behavioral abnormalities were observed in vaccinated swine and virus particles were not detected in either tissues or body fluids, indicating that this formulation was safe. The recombinant virus stimulated an effective level of antibody response in the immunized swine after a single intramuscular inoculation.
References
Jan 1, 1990·Journal of Wildlife Diseases·C E RupprechtL G Schneider
Feb 1, 1990·The Journal of General Virology·H KawanoA Shichijo
Jan 1, 1983·Microbiology and Immunology·M ShinagawaG Sato
Aug 1, 1983·The Journal of General Virology·W H WunnerT J Wiktor
Jan 1, 1994·Revista Da Sociedade Brasileira De Medicina Tropical·S A NishiokaR S Nunes
May 1, 1996·Virology·Z Q XiangH C Ertl
Jul 13, 1996·The Veterinary Record·K Stöhr, F M Meslin
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·E Paoletti
Jul 22, 1998·Journal of Immunological Methods·F CliquetL Sagné
Jan 10, 2001·Journal of the American Veterinary Medical Association·S R JenkinsUNKNOWN National Association of State Public Health Veterinarians
Feb 13, 2001·Vaccine·M LambotP P Pastoret
Apr 26, 2002·Vaccine·Channarong MitmoonpitakHenry Wilde
May 30, 2002·Vaccine·Kate AspdenAnna-Lise Williamson
Sep 26, 2002·Vaccine·Laurent FischerJean-Christophe Audonnet
Jun 24, 2003·Comparative Immunology, Microbiology and Infectious Diseases·P-P Pastoret, A Vanderplasschen
Mar 10, 2006·Microbes and Infection·Rongliang HuYueqiang Xiao
Jul 5, 2006·Viral Immunology·Ye LiuLiulian Chen
Nov 10, 2006·Journal of Wildlife Diseases·Jesse D BlantonCharles E Rupprecht
Jun 20, 2007·Vaccine·R L HuA R Fooks
Citations
Aug 2, 2014·PloS One·Xiaoning HeLi Lu
Sep 30, 2009·PLoS Neglected Tropical Diseases·Hildegund C J Ertl
May 25, 2012·PloS One·Junling QinXianzhu Xia
Jan 10, 2013·PloS One·Vanessa ContrerasIsabelle Schwartz-Cornil
Jul 12, 2014·PloS One·José M RojasVerónica Martín
Sep 16, 2009·Journal of Virological Methods·María Mercedes SeguraMiguel Chillón
Mar 7, 2009·The Journal of General Virology·Marion SzelechowskiBernard Klonjkowski
Feb 11, 2014·Journal of Wildlife Diseases·Jinghui ZhaoRongliang Hu
May 23, 2015·Applied Microbiology and Biotechnology·R CastroA S Coroadinha
Nov 26, 2013·Vaccine·José M RojasVerónica Martín
Dec 8, 2010·Vaccine·Coraline Bouet-CararoBernard Klonjkowski
May 22, 2013·PloS One·Érica Araújo MendesBraulia C Caetano
Jul 18, 2012·Human Gene Therapy Methods·María Mercedes SeguraMiguel Chillón
Nov 5, 2014·PloS One·Coraline Bouet-CararoBernard Klonjkowski
Dec 28, 2012·Journal of Virology·Zhenhai ChenBiao He
Oct 28, 2019·Nanomaterials·Baoqing PeiXiaoming Li
May 22, 2019·BioMed Research International·Ran ZhangLi Lu
Aug 29, 2021·Viruses·Marwa AlhashimiSuresh K Mittal
Sep 28, 2021·Frontiers in Veterinary Science·José M RojasVerónica Martín